Abstract

We determined the bone mineral density (BMD) and the expression of serum bone formation marker (procollagen type I N-terminal propeptide: PINP) and bone resorption marker (C-terminal telopeptide of collagen: CTX) by ELISA to evaluate ovariectomy-induced osteoporosis in ovariectomized (OVX) mice. The intestinal microbiota of the mice was assessed using 16S rRNA gene sequencing. OVX mice exhibited a lower BMD of 87% with higher serum levels of CTX and PINP compared to sham-operated (sham) mice. The cecum microbiome of OVX mice showed lower bacterial diversity than that of sham mice. TNFα mRNA levels in the colon were 1.6 times higher, and zonula occludens-1 mRNA and protein expression were lower in OVX mice than in sham mice, suggesting that ovariectomy induced inflammation and increased intestinal permeability. Next, we used antibiotic treatment followed by fecal microbiota transplantation (FMT) to remodel the gut microbiota in the OVX mice. A decrease in PINP was observed in antibiotic-treated mice, while there was no change in BMD or CTX between mice with and without antibiotic treatment. Oral transplantation of the luminal cecal content of OVX or sham mice to antibiotic-treated mice did not affect the BMD or PINP and CTX expression. Additionally, transplantation of the luminal contents of OVX or sham mice to antibiotic-treated OVX mice had similar effects on BMD, PINP, and CTX. In conclusion, although ovariectomy induces dysbiosis in the colon, the changes in the gut microbiota may only have a minor role in ovariectomy-induced osteoporosis.

Highlights

  • Osteoporosis is characterized by decreased bone mass and microarchitectural disruption and is the most common bone metabolic disease

  • We found that ovariectomy decreased colonic microbial richness

  • Estrogen deficiency affects the microbiota of the colon, but the effect of dysbiosis on bone homeostasis was not evident

Read more

Summary

Introduction

Osteoporosis is characterized by decreased bone mass and microarchitectural disruption and is the most common bone metabolic disease. Women are at increased risk for osteoporosis than men primarily due to the decline in estrogen levels after menopause [1]. Other factors include a lower amount of bone mass and the inadequate consumption of nutrients during pregnancy. Bone mass is maintained by the balance between osteoblast formation and bone resorption by osteoclasts. Estrogen deficiency causes uncoupled bone remodeling, leading to bone loss. This could be attributed to estrogen’s role in inhibiting osteoclast differentiation and promoting osteoclast apoptosis while inhibiting apoptosis of osteoblasts [2]. Inflammation induces osteoclast differentiation and causes excessive bone resorption [3], suggesting that systemic diseases can affect bone mass

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call